✦ LIBER ✦

Tolerability, efficacy and cognitive effects of quetiapine in patients with Parkinson's disease treated for psychotic symptoms

✍ Scribed by J.L. Juncos; M.L. Evatt; R.D. Jewart; V.J. Roberts; C.D. Wood; L.S. Potter; H.-C. Jou; P.P. Yeung

Book ID: 119574795
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 166 KB
Volume: 10
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(00)80352-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, safety, and tolerability of pr

Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease

✍ Ka Sing Wong; Chin-Song Lu; Din-E Shan; Chih-Chao Yang; Tak Hong Tsoi; Vincent M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 219 KB

Epidemiology of cognitive impairment and

Epidemiology of cognitive impairment and depressive symptoms in patients with Parkinson's disease

✍ Irena Rektorova; Martin Bares; Robert Jech; Katerina Farnikova; Ivan Rektor; Jan 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Efficacy and tolerability of iloperidone

Efficacy and tolerability of iloperidone in elderly patients with psychotic and behavioural symptoms associated with dementia

✍ H. El-Bizri; D.B. Fairweather; A. Guven; R. Zaninelli 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Efficacy, safety and tolerability of ras

Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson’s disease

✍ E. Tolosa; M. B. Stern 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Efficacy and safety of quetiapine for de

Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia

✍ Kyoung-Uk Lee; Yang-Whan Jeon; Hae-Kook Lee; Tae-Youn Jun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

## Objective: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. ## Method: Thirty-nine patients fulfilling dsm-iv-tr diagnostic criteria for schizophrenia and had depressive symptoms were studied in a prospective 6-week open-label design

Efficacy and safety of choline alphoscer

Efficacy and safety of choline alphoscerate (cereton) in patients with parkinson’s disease with cognitive impairments

✍ O. S. Levin; L. A. Batukaeva; M. A. Anikina; N. A. Yunishchenko 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 158 KB